In the pharmaceutical therapeutics section, which disease is addressed?

• A. Rheumatic Fever
• B. Scarlet Fever
• C. Kawasaki Disease
• D. Measles

Answer: (C)

Kawasaki disease stands out because its treatment relies on targeted drug therapy to prevent heart complications. This pediatric vasculitis is treated with intravenous immunoglobulin (IVIG) given early to dampen the inflammatory process and markedly reduce the risk of coronary artery aneurysms. Alongside IVIG, high-dose aspirin is used in the acute phase for its anti-inflammatory effects, then continued at a low dose to provide antiplatelet protection for weeks to months, especially if there are any coronary findings. This specific pharmacologic regimen—immunomodulation with IVIG plus antiplatelet/anti-inflammatory therapy with aspirin—is what the pharmaceutical therapeutics section typically emphasizes. The other conditions listed are usually managed with antibiotics or supportive care (rheumatic fever and scarlet fever with antibiotics; measles with supportive care and vitamin A), not with the distinctive drug combination seen in Kawasaki disease.